A New Treatment Option for Mastalgia
- Conditions
- Mastalgia
- Interventions
- Device: TENS
- Registration Number
- NCT06168110
- Lead Sponsor
- Ankara University
- Brief Summary
The main objective of this study is to determine the effectiveness of transcutaneous electrical nerve stimulation (TENS) treatment on pain and quality of life in mastalgia, which treatment has not yet reached a consensus.
- Detailed Description
The main objective of this study is to determine the effectiveness of transcutaneous electrical nerve stimulation (TENS) treatment on pain and quality of life in mastalgia, which treatment has not yet reached a consensus. This randomized controlled clinical trial was completed with 20 women suffering from mastalgia. Patients were randomly assigned to the TENS treatment and sham application groups. Pain intensity, pain patterns and quality of life were evaluated with Breast Pain and SF-36 questionnaires before and 10 days after treatment in all patients.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 93
- Patients with mastalgia between 18 and 70 yrs old
- Previous or new diagnosis of diseases that may cause extramammary mastalgia (history of previous breast surgery; inflammatory and/or tumoral breast or chest disorders such as mastitis, fibrocystic breasts, breast cancer or chest malignancies etc.)
- Having with conditions that might prevent TENS application (pacemaker, metal prosthesis, epilepsy, etc.)
- Being unable or insufficient to fill the questionnaires.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Sham TENS TENS - TENS TENS -
- Primary Outcome Measures
Name Time Method Pain intensity Before and 10 days after treatment The Breast Pain Questionnaire (BPQ), derived from the McGill Pain Questionnaire, was used to assess breast pain intensity. It is a tool that aims to evaluate the severity, pattern, location, duration and frequency of breast pain. It is calculated on the basis of Visual analog scale (VAS) and present pain intensity (PPI) scores in addition to sensory and affective component scores. Regarding the final total BPQ scores, patients' pain severity classified as mild (0-100), moderate (100-200), and severe (\>200)
- Secondary Outcome Measures
Name Time Method Quality of life Before and 10 days after treatment The Turkish version of the Short Form-36 version 2 (SF-36v2) was used to assess QoL before and 10 days after treatment.
Trial Locations
- Locations (1)
Ankara Universityt School of Medicine
🇹🇷Ankara, Turkey